NCT00655655 2024-08-21Everolimus and Vatalanib in Treating Patients With Advanced Solid TumorsMayo ClinicPhase 1 Completed96 enrolled
NCT01204476 2016-07-15Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaNational Cancer Institute (NCI)Phase 1 Completed27 enrolled
NCT00962507 2013-02-15Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaCity of Hope Medical CenterPhase 1 Completed11 enrolled